Chicago Partners Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.2M | Buy |
59,244
+662
| +1% | +$142K | 0.3% | 69 |
|
|
2026
Q1 | $11.7M | Buy |
58,582
+6,927
| +13% | +$1.54M | 0.26% | 74 |
|
|
2025
Q4 | $11.3M | Sell |
51,655
-218
| -0.4% | -$49.7K | 0.28% | 74 |
|
|
2025
Q3 | $11.8M | Sell |
51,873
-648
| -1% | -$132K | 0.31% | 66 |
|
|
2025
Q2 | $10M | Buy |
52,521
+13,679
| +35% | +$2.54M | 0.29% | 72 |
|
|
2025
Q1 | $7.31M | Buy |
38,842
+3,952
| +11% | +$768K | 0.24% | 86 |
|
|
2024
Q4 | $6.23M | Buy |
34,890
+4,199
| +14% | +$772K | 0.21% | 100 |
|
|
2024
Q3 | $5.77M | Buy |
30,691
+161
| +0.5% | +$30K | 0.21% | 102 |
|
|
2024
Q2 | $5.7M | Buy |
30,530
+744
| +2% | +$123K | 0.22% | 98 |
|
|
2024
Q1 | $5.05M | Buy |
29,786
+3,316
| +13% | +$571K | 0.21% | 105 |
|
|
2023
Q4 | $4.35M | Sell |
26,470
-1,507
| -5% | -$220K | 0.2% | 105 |
|
|
2023
Q3 | $4.05M | Sell |
27,977
-46
| -0.2% | -$6.75K | 0.22% | 98 |
|
|
2023
Q2 | $4.19M | Buy |
28,023
+5,277
| +23% | +$774K | 0.22% | 105 |
|
|
2023
Q1 | $3.73M | Buy |
22,746
+1,106
| +5% | +$169K | 0.22% | 109 |
|
|
2022
Q4 | $3.14M | Buy |
21,640
+876
| +4% | +$134K | 0.19% | 116 |
|
|
2022
Q3 | $3.08M | Buy |
20,764
+2,386
| +13% | +$342K | 0.22% | 99 |
|
|
2022
Q2 | $2.64M | Sell |
18,378
-122
| -0.7% | -$18.6K | 0.19% | 108 |
|
|
2022
Q1 | $2.82M | Buy |
18,500
+618
| +3% | +$89.8K | 0.22% | 99 |
|
|
2021
Q4 | $2.56M | Buy |
17,882
+721
| +4% | +$85.2K | 0.18% | 109 |
|
|
2021
Q3 | $2M | Buy |
17,161
+2,267
| +15% | +$259K | 0.14% | 144 |
|
|
2021
Q2 | $1.75M | Buy |
14,894
+63
| +0.4% | +$7.09K | 0.13% | 141 |
|
|
2021
Q1 | $1.65M | Buy |
14,831
+1,262
| +9% | +$135K | 0.14% | 135 |
|
|
2020
Q4 | $1.5M | Buy |
13,569
+405
| +3% | +$38.9K | 0.14% | 130 |
|
|
2020
Q3 | $1.16M | Buy |
13,164
+2,398
| +22% | +$226K | 0.14% | 124 |
|
|
2020
Q2 | $1.05M | Sell |
10,766
-2,420
| -18% | -$213K | 0.13% | 127 |
|
|
2020
Q1 | $1.1M | Sell |
13,186
-221
| -2% | -$18.8K | 0.17% | 101 |
|
|
2019
Q4 | $1.2M | Buy |
13,407
+404
| +3% | +$33.5K | 0.15% | 109 |
|
|
2019
Q3 | $999K | Buy |
13,003
+271
| +2% | +$18.6K | 0.14% | 108 |
|
|
2019
Q2 | $866K | Buy |
12,732
+3,943
| +45% | +$310K | 0.12% | 122 |
|
|
2019
Q1 | $682K | Sell |
8,789
-5,750
| -40% | -$470K | 0.1% | 146 |
|
|
2018
Q4 | $1.28M | Sell |
14,539
-6,401
| -31% | -$563K | 0.19% | 97 |
|
|
2018
Q3 | $1.7M | Buy |
20,940
+7,420
| +55% | +$704K | 0.25% | 68 |
|
|
2018
Q2 | $1.25M | Buy |
13,520
+798
| +6% | +$77.9K | 0.19% | 91 |
|
|
2018
Q1 | $1.2M | Buy |
12,722
+1,297
| +11% | +$142K | 0.21% | 88 |
|
|
2017
Q4 | $1.1M | Sell |
11,425
-2,006
| -15% | -$189K | 0.18% | 97 |
|
|
2017
Q3 | $1.19M | Sell |
13,431
-2,838
| -17% | -$216K | 0.2% | 90 |
|
|
2017
Q2 | $1.1M | Buy |
16,269
+9,569
| +143% | +$643K | 0.29% | 68 |
|
|
2017
Q1 | $437K | Sell |
6,700
-1,010
| -13% | -$63.5K | 0.12% | 119 |
|
|
2016
Q4 | $483K | Buy |
7,710
+10
| +0.1% | +$610 | 0.18% | 99 |
|
|
2016
Q3 | $486K | Buy |
7,700
+6,371
| +479% | +$412K | 0.19% | 96 |
|
|
2016
Q2 | $82K | Buy |
1,329
+1,201
| +938% | +$73.2K | 0.04% | 203 |
|
|
2016
Q1 | $7K | Sell |
128
-249
| -66% | -$13.9K | ﹤0.01% | 366 |
|
|
2015
Q4 | $22K | Sell |
377
-32
| -8% | -$1.84K | 0.01% | 334 |
|
|
2015
Q3 | $22K | Buy |
409
+2
| +0.5% | +$130 | 0.01% | 276 |
|
|
2015
Q2 | $27K | Buy |
407
+45
| +12% | +$2.94K | 0.01% | 274 |
|
|
2015
Q1 | $24K | Sell |
362
-120
| -25% | -$7.25K | 0.01% | 273 |
|
|
2014
Q4 | $32K | Buy |
+482
| New | +$30.4K | 0.01% | 252 |
|
Other funds holding ABBV
Chicago Partners Investment Group's ABBV Position: Q2 2026 in Review
Chicago Partners Investment Group increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $142K and bringing the position to 59,244 shares worth $15.2M. The position accounts for 0.3% of the portfolio, ranked #69.
Chicago Partners Investment Group first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Chicago Partners Investment Group held 59,244 shares of AbbVie worth $15.2M as of Q2 2026.
- Chicago Partners Investment Group bought 662 AbbVie shares in Q2 2026, an estimated $142K.
- AbbVie made up 0.3% of Chicago Partners Investment Group's portfolio in Q2 2026, its #69 holding.
- Chicago Partners Investment Group first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.